OESOPHAGEAL SQUAMOUS CELL CARCINOMA RECURRENT

OESOPHAGEAL SQUAMOUS CELL CARCINOMA RECURRENT was reported 12 times

OESOPHAGEAL SQUAMOUS CELL CARCINOMA RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Orexin Receptor Antagonist [EPC] 1 0.0001
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 5 0.0001
2 Platinum-based Drug [EPC] 7 0.0000
3 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
4 Microtubule Inhibitor [EPC] 3 0.0000
5 Topoisomerase Inhibitor [EPC] 1 0.0000
6 Proteasome Inhibitor [EPC] 1 0.0000
7 Alkylating Drug [EPC] 2 0.0000
8 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
9 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
10 Expectorant [EPC] 1 0.0000
11 Opioid Agonist [EPC] 1 0.0000
12 Osmotic Laxative [EPC] 1 0.0000
13 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
14 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
15 Corticosteroid [EPC] 2 0.0000